⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

IDXX

IDEXX Laboratories, Inc.

Healthcare · Diagnostics & Research

515.15USD

-5.0600 (-0.97%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 515.15
P/E35.6
Dvd Ind Yld—
P/B25.17
P/S8.9
Curr EV/T12M EBITDA25.7
Mkt Cap (USD)40.6B
Curr EV (USD)41.5B
2)

Per Share Data

EPS T12M14.20
DPS—
Bk Val Per Sh20.45
Rev/Sh57.41
Cash/Sh2.50
Curr Shares Out78.8M
FCF/Sh15.82
3)

Cash Flow Analysis

P/CF29.6
Curr P/FCF32.4
CF/NI1.2
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales30.1%
Eff Interest Rate7.8%
4)

Growth Potential

Dil EPS 1Y Gr22.6%
Cap 1Y Gr-7.1%
BPS 1Y Gr3.4%
R&D To Sales5.7%
Retention Rate100.0%
Rev 1Y Gr10.4%
FCF 1Y Gr30.8%
Assets 1Y Gr1.7%
5)

Profitability

EBITDA1.6B
EBIT1.5B
Operating Margin32.0%
Pretax Margin31.3%
Net Margin25.0%
ROA33.7%
ROE74.2%
ROC56.6%
Asset Turnover1.34
6)

Structure

Current Ratio1.17
Quick Ratio0.73
Debt/Assets13.1%
Debt/Com Eq27.9%
Net Debt/EBITDA0.16
Tot Debt/Capital21.8%
Gross Margin62.4%
EBIT/Int Exp38.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.